Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
Clinical trial NCT00100243 · COMPLETED
Trial details
- NCT number
- NCT00100243
- Sponsor
- PRAECIS Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.